JP2024109660A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024109660A5 JP2024109660A5 JP2024076686A JP2024076686A JP2024109660A5 JP 2024109660 A5 JP2024109660 A5 JP 2024109660A5 JP 2024076686 A JP2024076686 A JP 2024076686A JP 2024076686 A JP2024076686 A JP 2024076686A JP 2024109660 A5 JP2024109660 A5 JP 2024109660A5
- Authority
- JP
- Japan
- Prior art keywords
- site
- pam
- pam site
- spacer
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025170065A JP2026012727A (ja) | 2019-02-02 | 2025-10-08 | 遺伝子編集における非意図的な変異の阻害 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/074577 | 2019-02-02 | ||
| CN2019074577 | 2019-02-02 | ||
| JP2021544682A JP7518549B2 (ja) | 2019-02-02 | 2020-02-03 | 遺伝子編集における非意図的な変異の阻害 |
| PCT/CN2020/074218 WO2020156575A1 (en) | 2019-02-02 | 2020-02-03 | Inhibition of unintended mutations in gene editing |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544682A Division JP7518549B2 (ja) | 2019-02-02 | 2020-02-03 | 遺伝子編集における非意図的な変異の阻害 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025170065A Division JP2026012727A (ja) | 2019-02-02 | 2025-10-08 | 遺伝子編集における非意図的な変異の阻害 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024109660A JP2024109660A (ja) | 2024-08-14 |
| JP2024109660A5 true JP2024109660A5 (cg-RX-API-DMAC7.html) | 2024-09-12 |
| JP7761294B2 JP7761294B2 (ja) | 2025-10-28 |
Family
ID=71841894
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544682A Active JP7518549B2 (ja) | 2019-02-02 | 2020-02-03 | 遺伝子編集における非意図的な変異の阻害 |
| JP2024076686A Active JP7761294B2 (ja) | 2019-02-02 | 2024-05-09 | 遺伝子編集における非意図的な変異の阻害 |
| JP2025170065A Pending JP2026012727A (ja) | 2019-02-02 | 2025-10-08 | 遺伝子編集における非意図的な変異の阻害 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021544682A Active JP7518549B2 (ja) | 2019-02-02 | 2020-02-03 | 遺伝子編集における非意図的な変異の阻害 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025170065A Pending JP2026012727A (ja) | 2019-02-02 | 2025-10-08 | 遺伝子編集における非意図的な変異の阻害 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11384353B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3918083A4 (cg-RX-API-DMAC7.html) |
| JP (3) | JP7518549B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR102964723B1 (cg-RX-API-DMAC7.html) |
| CN (4) | CN116656676A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2020214090B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021015092A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3128283A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL285194A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202108303SA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020156575A1 (cg-RX-API-DMAC7.html) |
| ZA (2) | ZA202105895B (cg-RX-API-DMAC7.html) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4244369A4 (en) * | 2020-11-12 | 2024-10-16 | Shanghaitech University | GENOME EDITING OF IMPROVED EFFICIENCY AND ACCURACY |
| CN112575014B (zh) * | 2020-12-11 | 2022-04-01 | 安徽省农业科学院水稻研究所 | 一种碱基编辑器SpCas9-LjCDAL1及其构建和应用 |
| CN115161316B (zh) * | 2021-04-02 | 2025-12-23 | 上海科技大学 | 一种引导编辑工具、融合rna及其用途 |
| EP4314308A4 (en) * | 2021-04-02 | 2026-05-20 | Univ Shanghai Technology | GENE THERAPY FOR THE TREATMENT OF BETA-HEMOGLOBINOPATHIES |
| EP4330389A4 (en) * | 2021-04-30 | 2025-04-30 | Alnylam Pharmaceuticals, Inc. | RISC REORIENTATION FOR RNA EDITING |
| US12123006B2 (en) * | 2021-05-18 | 2024-10-22 | Shanghaitech University | Base editing tool and use thereof |
| WO2023283092A1 (en) * | 2021-07-06 | 2023-01-12 | Prime Medicine, Inc. | Compositions and methods for efficient genome editing |
| US20250019724A1 (en) * | 2021-11-18 | 2025-01-16 | Correctsequence Therapeutics | Regeneration of surface antigen-negative cells |
| KR102667508B1 (ko) * | 2022-02-08 | 2024-06-11 | 주식회사 툴젠 | 프라임 에디팅 시스템을 이용한 게놈 편집의 과정에서 발생 가능한 오프 타겟을 예측하는 방법 |
| WO2023155901A1 (en) * | 2022-02-17 | 2023-08-24 | Correctsequence Therapeutics | Mutant cytidine deaminases with improved editing precision |
| CN119998446A (zh) | 2022-06-07 | 2025-05-13 | 斯克里贝治疗公司 | 用于靶向pcsk9的组合物和方法 |
| WO2024012435A1 (en) | 2022-07-11 | 2024-01-18 | CorrectSequence Therapeutics Co., Ltd | Gene editing systems and methods for treating hereditary angioedema |
| WO2024042489A1 (en) | 2022-08-25 | 2024-02-29 | LifeEDIT Therapeutics, Inc. | Chemical modification of guide rnas with locked nucleic acid for rna guided nuclease-mediated gene editing |
| EP4608979A1 (en) * | 2022-10-28 | 2025-09-03 | CorrectSequence Therapeutics (Shanghai) Co., Ltd | Gene editing systems and methods for reducing immunogenicity and graft versus host response |
| IL320573A (en) | 2022-11-04 | 2025-07-01 | Life Edit Therapeutics Inc | Developed adenine deaminases and RNA-guided nuclease fusion proteins with internal insertion sites and methods of use |
| WO2024109745A1 (en) * | 2022-11-21 | 2024-05-30 | CorrectSequence Therapeutics Co., Ltd | Gene editing systems and methods for treating hbv infection |
| EP4622662A1 (en) * | 2022-11-23 | 2025-10-01 | Amber Bio Inc. | Gene-modifying endonucleases |
| WO2024127369A1 (en) | 2022-12-16 | 2024-06-20 | LifeEDIT Therapeutics, Inc. | Guide rnas that target foxp3 gene and methods of use |
| WO2024127370A1 (en) | 2022-12-16 | 2024-06-20 | LifeEDIT Therapeutics, Inc. | Guide rnas that target trac gene and methods of use |
| CN116286740A (zh) * | 2023-02-24 | 2023-06-23 | 四川大学华西医院 | 碱基编辑器和引导编辑器及构建与应用 |
| WO2024178397A2 (en) | 2023-02-24 | 2024-08-29 | Elevatebio Technologies, Inc. | Modified immune effector cells and methods of use |
| CN121100181A (zh) * | 2023-05-26 | 2025-12-09 | 正序(上海)生物医药科技有限公司 | 基因编辑系统及其用途 |
| EP4750890A2 (en) | 2023-07-27 | 2026-06-03 | Life Edit Therapeutics, Inc. | Rna-guided nucleases and active fragments and variants thereof and methods of use |
| EP4780862A1 (en) * | 2023-09-21 | 2026-07-29 | Shanghaitech University | Rna editing systems of high efficiency and specificity |
| WO2025081042A1 (en) | 2023-10-12 | 2025-04-17 | Renagade Therapeutics Management Inc. | Nickase-retron template-based precision editing system and methods of use |
| CN122422501A (zh) | 2023-10-18 | 2026-07-17 | 生命编辑治疗股份有限公司 | Rna引导的核酸酶及其活性片段和变体以及使用方法 |
| CN117092084B (zh) * | 2023-10-20 | 2024-01-12 | 浙江迪福润丝生物科技有限公司 | Wnv蛋白酶抑制剂的筛选方法和抑制效果评价方法 |
| WO2025140399A1 (en) * | 2023-12-26 | 2025-07-03 | Correctsequence Therapeutics (Shanghai) Co., Ltd | Gene editing systems and methods for treating cardiovascular disease |
| WO2025174908A1 (en) | 2024-02-12 | 2025-08-21 | Life Edit Therapeutics, Inc. | Novel rna-guided nucleases and proteins for polymerase editing |
| WO2025185623A1 (en) * | 2024-03-04 | 2025-09-12 | Shanghaitech University | Virus-like particles for gene editing |
| TW202617985A (zh) | 2024-06-25 | 2026-05-01 | 美商生命編輯治療學公司 | 新穎反轉錄酶及其用途 |
| WO2026026929A1 (en) * | 2024-07-31 | 2026-02-05 | Correctsequence Therapeutics (Shanghai) Co., Ltd | Gene editing systems and methods for treating obesity and metabolic dysfunction and associated diseases |
| CN118995709B (zh) * | 2024-08-23 | 2026-08-07 | 东北农业大学 | 一种提高基因编辑效率的重组型pegRNA及其应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6445314A (en) | 1987-04-16 | 1989-02-17 | Res Corp Technologies Inc | Antitumoral |
| US8288094B2 (en) | 2008-04-09 | 2012-10-16 | Institut Pasteur | APOBEC3 mediated DNA editing |
| US8399219B2 (en) * | 2009-02-23 | 2013-03-19 | Cytomx Therapeutics, Inc. | Protease activatable interferon alpha proprotein |
| CN111206032B (zh) * | 2013-12-12 | 2024-07-19 | 布罗德研究所有限公司 | 用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用 |
| WO2015089473A1 (en) * | 2013-12-12 | 2015-06-18 | The Broad Institute Inc. | Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation |
| US20150166984A1 (en) * | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting alpha-antitrypsin point mutations |
| CN105886498A (zh) * | 2015-05-13 | 2016-08-24 | 沈志荣 | CRISPR-Cas9特异性敲除人PCSK9基因的方法以及用于特异性靶向PCSK9基因的sgRNA |
| WO2017070632A2 (en) * | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| EP3445853A1 (en) * | 2016-04-19 | 2019-02-27 | The Broad Institute, Inc. | Cpf1 complexes with reduced indel activity |
| WO2018052247A1 (ko) * | 2016-09-13 | 2018-03-22 | 주식회사 툴젠 | 시토신 디아미나제에 의한 dna에서의 염기 교정 확인 방법 |
| US11192929B2 (en) * | 2016-12-08 | 2021-12-07 | Regents Of The University Of Minnesota | Site-specific DNA base editing using modified APOBEC enzymes |
| KR102569848B1 (ko) * | 2016-12-23 | 2023-08-25 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | Pcsk9의 유전자 편집 |
| CN108342387B (zh) | 2017-01-24 | 2021-09-24 | 谭旭 | Pcsk9抑制剂类降血脂药的递送系统和生物制剂 |
| JP7277052B2 (ja) * | 2017-02-22 | 2023-05-18 | クリスパー セラピューティクス アーゲー | プロタンパク質転換酵素サブチリシン/ケキシン9型(pcsk9)関連障害の処置のための組成物および方法 |
| IL306092A (en) * | 2017-03-23 | 2023-11-01 | Harvard College | Nucleic base editors that include nucleic acid programmable DNA binding proteins |
| WO2018208998A1 (en) * | 2017-05-10 | 2018-11-15 | The Regents Of The University Of California | Directed editing of cellular rna via nuclear delivery of crispr/cas9 |
| CA3063733A1 (en) * | 2017-05-25 | 2018-11-29 | The General Hospital Corporation | Base editors with improved precision and specificity |
| CN109136272A (zh) | 2017-06-15 | 2019-01-04 | 中山大学 | 用于特异性修复人hbb基因突变的碱基编辑系统、方法、试剂盒及其在人生殖系中的应用 |
| SG11201912024RA (en) * | 2017-07-31 | 2020-02-27 | Sigma Aldrich Co Llc | Synthetic guide rna for crispr/cas activator systems |
| CN109021111B (zh) * | 2018-02-23 | 2021-12-07 | 上海科技大学 | 一种基因碱基编辑器 |
-
2020
- 2020-02-03 JP JP2021544682A patent/JP7518549B2/ja active Active
- 2020-02-03 WO PCT/CN2020/074218 patent/WO2020156575A1/en not_active Ceased
- 2020-02-03 KR KR1020217028085A patent/KR102964723B1/ko active Active
- 2020-02-03 CN CN202211043562.5A patent/CN116656676A/zh active Pending
- 2020-02-03 CA CA3128283A patent/CA3128283A1/en active Pending
- 2020-02-03 CN CN202211057011.4A patent/CN116355966A/zh active Pending
- 2020-02-03 CN CN202080026986.3A patent/CN113661248B/zh active Active
- 2020-02-03 EP EP20748289.4A patent/EP3918083A4/en active Pending
- 2020-02-03 SG SG11202108303SA patent/SG11202108303SA/en unknown
- 2020-02-03 AU AU2020214090A patent/AU2020214090B2/en active Active
- 2020-02-03 BR BR112021015092A patent/BR112021015092A2/pt unknown
- 2020-02-03 US US17/427,040 patent/US11384353B2/en active Active
- 2020-02-03 CN CN202211042699.9A patent/CN116286802A/zh active Pending
- 2020-02-03 KR KR1020267014057A patent/KR20260067381A/ko active Pending
-
2021
- 2021-07-28 IL IL285194A patent/IL285194A/en unknown
- 2021-08-17 ZA ZA2021/05895A patent/ZA202105895B/en unknown
-
2022
- 2022-07-11 US US17/862,354 patent/US11840685B2/en active Active
- 2022-11-16 ZA ZA2022/12490A patent/ZA202212490B/en unknown
- 2022-12-12 AU AU2022287550A patent/AU2022287550B2/en active Active
-
2023
- 2023-09-29 US US18/478,861 patent/US20240026342A1/en active Pending
-
2024
- 2024-05-09 JP JP2024076686A patent/JP7761294B2/ja active Active
-
2025
- 2025-10-08 JP JP2025170065A patent/JP2026012727A/ja active Pending
- 2025-10-24 AU AU2025256226A patent/AU2025256226A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Van Dijk et al. | Library preparation methods for next-generation sequencing: tone down the bias | |
| EP3192869B1 (en) | Isolated oligonucleotide and use thereof in nucleic acid sequencing | |
| JP6894501B2 (ja) | 等温核酸自己増幅法 | |
| US20100035249A1 (en) | Rna sequencing and analysis using solid support | |
| JP2002519038A5 (cg-RX-API-DMAC7.html) | ||
| DK1314783T3 (da) | Nukleinsyrelinkere og deres anvendelse i gensyntese | |
| JP2025084823A (ja) | リプログラミングされたtracrRNAを用いたRNA検出及び転写依存性編集 | |
| JP2022547949A (ja) | シーケンシングのためのrna試料を調製する方法およびそのキット | |
| JP2023549125A5 (cg-RX-API-DMAC7.html) | ||
| CN108251503A (zh) | 一种快速构建链特异性rna高通量测序文库的方法 | |
| CN114293264B (zh) | 酶法靶序列随机sgRNA文库的制备方法 | |
| JP2006506953A5 (cg-RX-API-DMAC7.html) | ||
| US20250066752A1 (en) | Crispr-based programmable rna editing | |
| JP7550761B2 (ja) | 一本鎖dnaの合成方法 | |
| CN116590322A (zh) | 一种crispr-mcpn载体及其构建方法、应用 | |
| US8470537B2 (en) | Sequential addition of short DNA oligos in DNA-polymerase-based synthesis reactions | |
| WO2021192596A1 (ja) | 連結dnaの製造方法及びそれに用いるためのベクターの組み合わせ | |
| US11572554B2 (en) | Target irrelevant guide RNA for CRISPR | |
| JP2023538537A (ja) | 核酸の標的化除去のための方法 | |
| JP4509307B2 (ja) | RecAタンパク質を用いてライブラリーを加工する方法 | |
| US20030180781A1 (en) | Constructing very long DNA sequences from synthetic DNA molecules | |
| US20250354177A1 (en) | System and methods for duplicating target fragments | |
| EP1295942B1 (en) | Method for processing a library using ligation inhibition | |
| US20030104467A1 (en) | Process for preparation of full-length cDNA and anchor used for the same | |
| JP2023545403A5 (cg-RX-API-DMAC7.html) |